Clinical and Cost Effectiveness of Different Dressing Materials in Diabetic Foot Ulcers
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of the study is to evaluate the efficacy and safety of different commonly used dressings for treating diabetic foot ulcers. It is a prospective study recruiting 50 type 2 diabetic patients with diabetic foot ulcers (2-50cm2). All the patients will give written informed consent prior to getting enrolled in the study. All the patients will be randomly assigned to one of the five groups of the study namely, saline (control),Biatin Ag (Foam), Hydrocolloid, Hydrogel and Ceredak. Follow up of the patients will be done until the complete healing of the wound takes place. All procedures of dressing will be done by an authorized and certified Podiatric Surgeon of the Institution. Details on the cost incurred and days required for the wound to completely heal will be recorded for all the patients.
This study will provide the efficacy of all the dressings used for treating diabetic foot ulcers and also the cost of each dressing. This will help the surgeons for managing the diabetic foot ulcers in a better and cost effective way, which in turn will reduce the burden of patients both physically and financially.
| Condition | Intervention |
|---|---|
|
Diabetic Foot Ulcers |
Procedure: Normal Saline Procedure: Biatin Ag (Foam) Procedure: Hydrocolloid Procedure: Hydrogel Procedure: Ceredak |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
- complete healing of the wound [ Time Frame: 1 months from the date of application ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 50 |
| Study Start Date: | October 2009 |
| Estimated Study Completion Date: | July 2012 |
| Estimated Primary Completion Date: | July 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Active Comparator: Group 1 |
Procedure: Normal Saline
All the subjects in Group 1 will be treated with Normal Saline for healing of their diabetic foot ulcer
|
| Active Comparator: Group 2 |
Procedure: Biatin Ag (Foam)
All the subjects will be treated with Biatin Ag (Foam)
Other Name: Coloplast
|
| Active Comparator: Group 3 |
Procedure: Hydrocolloid
All the subjects in this group will be treated with Hydrocolloid
Other Name: Coloplast
|
| Active Comparator: Group 4 |
Procedure: Hydrogel
All the subjects in this group will be treated with Hydrogel
Other Name: Coloplast - Purilon Gel
|
| Active Comparator: Group 5 |
Procedure: Ceredak
All the subjects in this group will be treated with Micro-porous Ceramic Wound Dressing
Other Name: Ceredak
|
Detailed Description:
This prospective study aims at determining the efficacy and safety of different dressings available for treating diabetic foot ulcers. Study has been approved by the Institutional Ethics Committee before starting. Informed consent will be obtained from all the study subjects. A total of 50 subjects will be recruited. Study subjects will be divided in five groups of 10 subjects in each group.All the subjects will be randomly assigned to one of the study groups namely; Group 1 will the subjects randomized on Normal Saline (Control) and group 2 will be the subjects randomized on Biatin Ag (Foam) dressing; Group 3 will be Hydrocolloid, group 4 will be Hydrogel and Group 5 will be Ceredak. Lab investigations involving glycemic status (HbA1c), lipid profile, renal function test, liver function test will be done using standard enzymatic procedures. Wound size, colony count and microflora of the wound will be captured for all the study subjects. Photographs of the wound will be taken at every follow up visit until the wound is healed. Serum and tissue sample will be collected for the estimation of pronounced markers like MMP 2 and MMP 9. MMP 2 will be estimated using ELISA procedure (using standard enzymatic assay kit) and MMP 9 will be estimated using western blot technique. Histopathology of collagen will be seen using Van Gieson's stain. Immunohistochemistry will be done for determining collagen IV (marker for basement membrane thickening) to prove the evident wound healing at a defined point of time. H&E sections will be taken for determining the inflammation histochemically. All the study subjects will be followed till the wound healing process is complete. Tissue and serum samples will be collected for the above mentioned parameters on pre application day, after 1st and 4th week of the dressing application. A total of 3 visits will be performed for all the study subjects.
Eligibility| Ages Eligible for Study: | 35 Years to 75 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients with foot ulcers
- Patients with or without PVD
- Size of the ulcer: 2-50 cm2
- Age 30-75 years (both gender)
Exclusion Criteria:
- Patient having severe infection
- Size of the foot ulcer > 50cm2
- Patients not willing to give written informed consent
- Patient with psychological disorder
- Patients with severe renal impairment or visual deformity
- Patients above the age of 75 years
Contacts and Locations| Contact: Mary Babu, Dr. | 044-25954913 ext 224 | babumary2000@yahoo.com |
| Contact: Vijay Viswanathan, Dr. | 044-25954915 ext 277 | drvijay@mvdiabetes.com |
| India | |
| Diabetes Research Centre | Recruiting |
| Chennai, Tamil Nadu, India, 600013 | |
| Contact: Vijay Viswanathan, Dr 044-25954915 ext 277 drvijay@mvdiabetes.com | |
| Contact: Rajesh Kesavan, Dr. 044-25954913 ext 277 dr_vijay@mvdiabetes.com | |
| Sub-Investigator: Mary Babu, Dr. | |
| Principal Investigator: | Vijay Viswanathan, Dr | DRC |
| Study Director: | Rajesh Kesavan, Dr. | DRC |
More Information
No publications provided
| Responsible Party: | Vijay Viswanathan, MANAGING DIRECTOR, M.V. Hospital for Diabetes |
| ClinicalTrials.gov Identifier: | NCT01105884 History of Changes |
| Other Study ID Numbers: | CDS01 |
| Study First Received: | April 16, 2010 |
| Last Updated: | April 21, 2012 |
| Health Authority: | India: Institutional Review Board |
Keywords provided by M.V. Hospital for Diabetes:
|
Wound healing, type 2 diabetes, diabetic foot ulcers, different dressings |
Additional relevant MeSH terms:
|
Ulcer Foot Ulcer Diabetic Foot Pathologic Processes Foot Diseases Skin Diseases Leg Ulcer Skin Ulcer |
Diabetic Angiopathies Vascular Diseases Cardiovascular Diseases Diabetes Complications Diabetes Mellitus Endocrine System Diseases Diabetic Neuropathies |
ClinicalTrials.gov processed this record on May 19, 2013